Baseline 12 months prior to LC | During 12 months during LC | Post 12 months after LC | p Value over time | |||||
Mean (SD) | Median | Mean (SD) | Median | Mean (SD) | Median | |||
Glycemic outcomes and management, patients with A1c ≥7.3%(QIIP: N=153; control: N=157) | ||||||||
A1c value, % | QIIP | 8.5 (1.25) | 8.1 | 8.1 (1.32) | 7.8 | 8.2 (1.62) | 7.9 | 0.10 |
Control | 8.5 (1.22) | 8.0 | 8.4 (1.51) | 8.0 | 8.4 (1.58) | 8.1 | ||
% | % | % | p Value* | |||||
A1c at CPG target (≤7.0%) | QIIP | No patients at target | 22.2 | 26.1 | 0.75 | |||
Control | 15.3 | 16.6 | ||||||
Prescribed an OHA | QIIP | 84.3 | 88.2 | 90.2 | 0.99 | |||
Control | 82.8 | 87.9 | 87.3 | |||||
Prescribed insulin | QIIP | 28.8 | 39.2 | 47.1 | 0.24 | |||
Control | 35.0 | 42.7 | 49.7 | |||||
Hypertension outcomes and management, all patients(QIIP: N=406; control: N=403) | ||||||||
N | Mean (SD) | N | Mean (SD) | N | Mean (SD) | p Value over time | ||
Systolic BP value, mm Hg | QIIP | 344 | 129.8 (16.24) | 394 | 131.0 (17.17) | 400 | 130.7 (16.56) | 0.72 |
Control | 354 | 132.0 (17.50) | 387 | 130.7 (17.88) | 399 | 131.7 (16.27) | ||
Diastolic BP value, mm Hg | QIIP | 344 | 74.0 (9.49) | 394 | 73.6 (9.82) | 400 | 73.0 (9.36) | 0.92 |
Control | 354 | 74.9 (10.81) | 387 | 73.5 (10.73) | 399 | 73.7 (10.50) | ||
N | % | N | % | N | % | p Value over time | ||
BP at CPG target (≤130/80) | QIIP | 344 | 53.8 | 394 | 52.3 | 400 | 52.8 | 0.50 |
Control | 354 | 48.0 | 387 | 50.9 | 399 | 46.6 | ||
Prescribed an AHTN | QIIP | 406 | 79.1 | 406 | 87.0 | 406 | 89.2 | 0.22 |
Control | 403 | 79.4 | 403 | 84.9 | 403 | 86.3 | ||
Lipid outcomes and management, all patients(QIIP: N=406; control: N=403) | ||||||||
N | Mean (SD) | N | Mean (SD) | N | Mean (SD) | p Value over time | ||
LDL cholesterol value, mmol/L | QIIP | 284 | 2.2 (0.80) | 369 | 2.1 (0.80) | 385 | 2.0 (0.74) | 0.32 |
Control | 273 | 2.4 (0.82) | 353 | 2.3 (0.86) | 382 | 2.2 (0.79) | ||
N | % | N | % | N | % | p Value over time | ||
LDL cholesterol at CPG target (≤2.0) | QIIP | 284 | 43.0 | 369 | 52.6 | 385 | 59.2 | 0.03 |
Control | 273 | 34.8 | 353 | 40.5 | 382 | 44.5 | ||
% | % | % | p Value over time | |||||
Prescribed a statin | QIIP | 67.0 | 78.6 | 84.2 | 0.97 | |||
Control | 59.1 | 72.5 | 74.2 |